New Delhi: India will be deploying its vast election machinery to administer 60 crore doses in the next 6 to 8 months using standard cold chain systems. The reason for ...
Washington: Hours after approving the Pfizer COVID-19 vaccine for emergency use, the US government placed an order to secure 100 million more doses from Moderna. Earlier, the US had decided ...
Singapore: Australia on Friday stopped a vaccine trial in phase 1 after several participants developed antibodies for HIV, though it's not a serious side effect. The vaccine, developed by University ...
New York: Pfizer has decided to keep a differential pricing on its COVID-19 vaccine, which will be based on a country's GDP. CEO Albert Bourla has said the vaccine will ...
New York: The US Food and Drug Administration (FDA) has revealed that the COVID-19 vaccine developed by Pfizer-BioNTech saw four volunteers developing temporary facial paralysis or Bell's palsy during the ...
London: Regulators have added allergic reaction warnings for Pfizer's COVID-19 vaccine. Anyone with a history of significant allergic reactions are advised not to have the vaccine shot. Two NHS staff ...
New Delhi: The Union government dismissed media reports of Serum Institute India (SII) and Bharat Biotech’s emergency use authorisation of COVID-19 vaccine being rejected and called it “fake.” According to ...
Moscow: Russian citizens are being advised to avoid alcohol for two months after receiving the country’s COVID-19 Sputnik V vaccine. Russian Deputy Prime Minister Tatiana Golikova said in an interview ...
New Delhi: The Central government will launch an app for the people to avail vaccine against COVID-19. Health secretary of the Union government Rajesh Bhusan on Tuesday said one can ...
London: Margaret Keenan, a 90-year-old woman, became the first person to receive COVID-19 vaccine outside of trials in the world. Keenan received the jab of the Pfizer vaccine at her ...
Copyright © 2025 Frontier Media
